Tibet Rhodiola Pharmaceutical Holding Co. (600211) Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Tibet Rhodiola Pharmaceutical Holding Co.

Why is Tibet Rhodiola Pharmaceutical Holding Co. ?

OPERATING CASH FLOW(Y) Lowest at CNY 971.52 MM
INVENTORY TURNOVER RATIO(HY) Lowest at 1.34 times
NET SALES(Q) Lowest at CNY 438.57 MM

With ROE of 24.43%, it has a very attractive valuation with a 3.55 Price to Book Value

Over the past year, while the stock has generated a return of 19.90%, its profits have fallen by -3%
At the current price, the company has a high dividend yield of 4

Real-Time Research Report

Verdict Report

How much should you hold?

Overall Portfolio exposure to Tibet Rhodiola Pharmaceutical Holding Co. should be less than 10%
Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is Tibet Rhodiola Pharmaceutical Holding Co. for you?

High Risk, Low Return

Absolute

Risk Adjusted

Volatility

Tibet Rhodiola Pharmaceutical Holding Co.

5.69%

0.45

36.51%

China Shanghai Composite

13.33%

1.58

14.20%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

15.72%

EBIT Growth (5y)

17.80%

EBIT to Interest (avg)

100.00

Debt to EBITDA (avg)

Net Debt to Equity (avg)

-0.64

Sales to Capital Employed (avg)

0.67

Tax Ratio

8.47%

Dividend Payout Ratio

60.00%

Pledged Shares

Institutional Holding

ROCE (avg)

38.04%

ROE (avg)

17.58%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

3.55

EV to EBIT

13.69

EV to EBITDA

12.90

EV to Capital Employed

6.80

EV to Sales

4.43

PEG Ratio

Dividend Yield

3.95%

ROCE (Latest)

49.70%

ROE (Latest)

24.43%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Bearish

Bullish

RSI

No Signal

Bollinger Bands

Bearish

Moving Averages

Bearish (Daily)

KST

Mildly Bullish

Bullish

Dow Theory

Mildly Bearish

OBV

No Trend

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

5What is working for the Company

ROCE(HY)

Highest at 27.33%

RAW MATERIAL COST(Y)

Fallen by 0.73% (YoY

CASH AND EQV(HY)

Highest at CNY 6,297.86 MM

DEBT-EQUITY RATIO (HY)

Lowest at -64.86 %

-13What is not working for the Company

OPERATING CASH FLOW(Y)

Lowest at CNY 971.52 MM

INVENTORY TURNOVER RATIO(HY)

Lowest at 1.34 times

NET SALES(Q)

Lowest at CNY 438.57 MM

OPERATING PROFIT(Q)

Lowest at CNY 135.24 MM

PRE-TAX PROFIT(Q)

Lowest at CNY 175.49 MM

NET PROFIT(Q)

Lowest at CNY 154.09 MM

EPS(Q)

Lowest at CNY 0.48

Here's what is working for Tibet Rhodiola Pharmaceutical Holding Co.

Cash and Eqv

Highest at CNY 6,297.86 MM

in the last six Semi-Annual periods

MOJO Watch

Short Term liquidity is improving

Cash and Cash Equivalents

Debt-Equity Ratio

Lowest at -64.86 %

in the last five Semi-Annual periods

MOJO Watch

The company has been reducing its borrowing as compared to equity capital

Debt-Equity Ratio

Raw Material Cost

Fallen by 0.73% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for Tibet Rhodiola Pharmaceutical Holding Co.

Net Sales

At CNY 438.57 MM has Fallen at -38.29%

over average net sales of the previous four periods of CNY 710.68 MM

MOJO Watch

Near term sales trend is extremely negative

Net Sales (CNY MM)

Operating Cash Flow

Lowest at CNY 971.52 MM

in the last three years

MOJO Watch

The company's cash revenues from business operations are falling

Operating Cash Flows (CNY MM)

Net Sales

Lowest at CNY 438.57 MM

in the last five periods

MOJO Watch

Near term sales trend is negative

Net Sales (CNY MM)

Operating Profit

Lowest at CNY 135.24 MM

in the last five periods

MOJO Watch

Near term Operating Profit trend is negative

Operating Profit (CNY MM)

Pre-Tax Profit

Lowest at CNY 175.49 MM

in the last five periods

MOJO Watch

Near term Pre-Tax Profit trend is negative

Pre-Tax Profit (CNY MM)

Pre-Tax Profit

At CNY 175.49 MM has Fallen at -37.28%

over average net sales of the previous four periods of CNY 279.81 MM

MOJO Watch

Near term Pre-Tax Profit trend is negative

Pre-Tax Profit (CNY MM)

Net Profit

Lowest at CNY 154.09 MM

in the last five periods

MOJO Watch

Near term Net Profit trend is negative

Net Profit (CNY MM)

Net Profit

At CNY 154.09 MM has Fallen at -39%

over average net sales of the previous four periods of CNY 252.61 MM

MOJO Watch

Near term Net Profit trend is negative

Net Profit (CNY MM)

EPS

Lowest at CNY 0.48

in the last five periods

MOJO Watch

Declining profitability; company has created lower earnings for shareholders

EPS (CNY)

Inventory Turnover Ratio

Lowest at 1.34 times

in the last five Semi-Annual periods

MOJO Watch

Company's pace of selling inventory has slowed

Inventory Turnover Ratio